SDI-based age-standardized rates of DALYs and ASDR for IHD attributable to HSBP. by Zhenhua Zhuang (11192745)

Subjects:

The 2021 Age-standardised rate of DALYs and deaths for ischemic heart disease attributable to high systolic blood pressure in 204 countries and territories. by Zhenhua Zhuang (11192745)

Subjects:

Table 1_Dexmedetomidine decreases cerebral hyperperfusion syndrome incidence following mechanical thrombectomy in acute ischemic stroke: a double-blind, randomized controlled trial... by Ziwen Gao (11627802)

Table 2_Dexmedetomidine decreases cerebral hyperperfusion syndrome incidence following mechanical thrombectomy in acute ischemic stroke: a double-blind, randomized controlled trial... by Ziwen Gao (11627802)

Table 3_Dexmedetomidine decreases cerebral hyperperfusion syndrome incidence following mechanical thrombectomy in acute ischemic stroke: a double-blind, randomized controlled trial... by Ziwen Gao (11627802)

Trend of total hospital attendance. by Yaw Nyarko Opoku-Boateng (20477302)

“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”

Trend of outpatient (OPD) consultations. by Yaw Nyarko Opoku-Boateng (20477302)

“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”

Variables used for the analysis. by Yaw Nyarko Opoku-Boateng (20477302)

“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”

Trend of PNC attendance over the period. by Yaw Nyarko Opoku-Boateng (20477302)

“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”

Trend of ANC attendance over the period. by Yaw Nyarko Opoku-Boateng (20477302)

“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”

Total hospital attendances by specialty. by Yaw Nyarko Opoku-Boateng (20477302)

“…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”

Additional file 9 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 8 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Supplementary Table S2 from Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4⁺ T Cells by Signe Caksa (16745174)

Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 11 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Presentation 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated... by Xiaokang Wang (733379)

“…</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”

Table 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated signall... by Xiaokang Wang (733379)

“…</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”

Additional file 10 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Disruption of the <i>pcnB</i> gene encoding poly(A) polymerase PAP I decreases pYV PCN as well as T3SS expression and activity. by Katherine Schubert (5452712)